Top

Published in:

Open Access 01-05-2019 | Perspective

Differences in the imaging of Crohn’s disease patients between North America and Europe: are we ready to bridge the divide?

Authors: Stuart A. Taylor, Florian Rieder, Joel G. Fletcher

Published in: Abdominal Radiology | Issue 5/2019

Abstract

The emphasis of treatment in Crohn’s disease has evolved from a reactive model to “treat-to-target” approaches. Cross-sectional imaging has rapidly evolved in parallel, with a growing evidence base supporting its abilities for diagnosis, monitoring and prognostication. Whilst there are differences in emphasis between Europe and North America, particularly around the type of imaging modalities and patterns of multidisciplinary care, there is increasing convergence. This perspective piece provides an overview of the evolving role of cross-sectional imaging in Crohn’s disease, discusses practice differences between North America and Europe and provides suggestions on areas for future collaboration and research priorities.

Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Pare P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG (2015) Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial. Lancet (London, England) 386(10006):1825-1834. https://doi.org/10.1016/s0140-6736(15)00068-9 CrossRef

Taylor SA, Mallett S, Bhatnagar G, Baldwin-Cleland R, Bloom S, Gupta A, Hamlin PJ, Hart AL, Higginson A, Jacobs I, McCartney S, Miles A, Murray CD, Plumb AA, Pollok RC, Punwani S, Quinn L, Rodriguez-Justo M, Shabir Z, Slater A, Tolan D, Travis S, Windsor A, Wylie P, Zealley I, Halligan S (2018) Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial. The lancet Gastroenterology & hepatology 3 (8):548-558. https://doi.org/10.1016/s2468-1253(18)30161-4 CrossRef

Bruining DH, Zimmermann EM, Loftus EV, Jr., Sandborn WJ, Sauer CG, Strong SA, Society of Abdominal Radiology Crohn's Disease-Focused P (2018) Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. Gastroenterology 154 (4):1172-1194. https://doi.org/10.1053/j.gastro.2017.11.274 CrossRefPubMed

Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, Vavricka SR, Verstockt B, van Rheenen P, Tolan D, Taylor SA, Rimola J, Rieder F, Limdi JK, Laghi A, Krustins E, Kotze PG, Kopylov U, Katsanos K, Halligan S, Gordon H, Gonzalez Lama Y, Ellul P, Eliakim R, Castiglione F, Burisch J, Borralho Nunes P, Bettenworth D, Baumgart DC, Stoker J (2018) ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjy114

Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, Gonzalez-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustins E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J (2018) ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjy113

Dietrich CF, Goudie A, Chiorean L, Cui XW, Gilja OH, Dong Y, Abramowicz JS, Vinayak S, Westerway SC, Nolsoe CP, Chou YH, Blaivas M (2017) Point of Care Ultrasound: A WFUMB Position Paper. Ultrasound in medicine & biology 43 (1):49-58. https://doi.org/10.1016/j.ultrasmedbio.2016.06.021 CrossRef

Kjesbu IE, Laursen CB, Graven T, Holden HM, Romo B, Newton Andersen G, Mjolstad OC, Lassen A, Dalen H (2017) Feasibility and Diagnostic Accuracy of Point-of-Care Abdominal Sonography by Pocket-Sized Imaging Devices, Performed by Medical Residents. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 36 (6):1195-1202. https://doi.org/10.7863/ultra.16.05077 CrossRef

Atkinson NS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH, Nolsoe C, Nurnberg D, Dietrich CF (2016) WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice. Ultrasound in medicine & biology 42 (12):2732-2742. https://doi.org/10.1016/j.ultrasmedbio.2016.08.026

Novak K, Tanyingoh D, Petersen F, Kucharzik T, Panaccione R, Ghosh S, Kaplan GG, Wilson A, Kannengiesser K, Maaser C (2015) Clinic-based Point of Care Transabdominal Ultrasound for Monitoring Crohn's Disease: Impact on Clinical Decision Making. Journal of Crohn's & colitis 9 (9):795-801. https://doi.org/10.1093/ecco-jcc/jjv105 CrossRef

10.

Guimaraes LS, Fidler JL, Fletcher JG, Bruining DH, Huprich JE, Siddiki H, Sandborn WJ, Loftus EV, Jr., Pardi DS, McCollough CH (2010) Assessment of appropriateness of indications for CT enterography in younger patients. Inflamm Bowel Dis 16 (2):226-232. https://doi.org/10.1002/ibd.21025 CrossRefPubMed

11.

Liu W, Liu J, Xiao W, Luo G (2017) A Diagnostic Accuracy Meta-analysis of CT and MRI for the Evaluation of Small Bowel Crohn Disease. Academic radiology 24 (10):1216-1225. https://doi.org/10.1016/j.acra.2017.04.013 CrossRefPubMed

12.

Del Gaizo AJ, Fletcher JG, Yu L, Paden RG, Spencer GC, Leng S, Silva AM, Fidler JL, Silva AC, Hara AK (2013) Reducing radiation dose in CT enterography. Radiographics 33 (4):1109-1124. https://doi.org/10.1148/rg.334125074 CrossRefPubMed

13.

Rosenfeld G, Brown J, Vos PM, Leipsic J, Enns R, Bressler B (2018) Prospective Comparison of Standard- Versus Low-Radiation-Dose CT Enterography for the Quantitative Assessment of Crohn Disease. AJR Am J Roentgenol 210 (2):W54-W62. https://doi.org/10.2214/AJR.17.18296 CrossRefPubMed

14.

Bruining DH, Siddiki HA, Fletcher JG, Sandborn WJ, Fidler JL, Huprich JE, Mandrekar JN, Harmsen WS, Evans PE, Faubion WA, Hanson KA, Ingle SB, Pardi DS, Schroeder KW, Tremaine WJ, Loftus EV, Jr. (2012) Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence. Inflamm Bowel Dis 18 (2):219-225. https://doi.org/10.1002/ibd.21683 CrossRefPubMed

15.

Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV, Jr. (2008) Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. Inflamm Bowel Dis 14 (12):1701-1706. https://doi.org/10.1002/ibd.20529 CrossRefPubMed

16.

Kerner C, Carey K, Mills AM, Yang W, Synnestvedt MB, Hilton S, Weiner MG, Lewis JD (2012) Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn's disease. Clin Gastroenterol Hepatol 10 (1):52-57. https://doi.org/10.1016/j.cgh.2011.09.005 CrossRefPubMed

17.

Taleban S, Colombel JF, Mohler MJ, Fain MJ (2015) Inflammatory bowel disease and the elderly: a review. Journal of Crohn's & colitis 9 (6):507-515. https://doi.org/10.1093/ecco-jcc/jjv059 CrossRef

18.

Everhov AH, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, Soderling J, Ekbom A, Neovius M, Ludvigsson JF, Askling J, Olen O (2018) Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology 154 (3):518-528 e515. https://doi.org/10.1053/j.gastro.2017.10.034

19.

Taleban S (2015) Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly. Curr Treat Options Gastroenterol 13 (3):275-286. https://doi.org/10.1007/s11938-015-0059-6 CrossRefPubMed

20.

Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60 (5):571-607. https://doi.org/10.1136/gut.2010.224154 CrossRefPubMed

21.

Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, Danese S, Halligan S, Marincek B, Matos C, Peyrin-Biroulet L, Rimola J, Rogler G, van Assche G, Ardizzone S, Ba-Ssalamah A, Bali MA, Bellini D, Biancone L, Castiglione F, Ehehalt R, Grassi R, Kucharzik T, Maccioni F, Maconi G, Magro F, Martin-Comin J, Morana G, Pendse D, Sebastian S, Signore A, Tolan D, Tielbeek JA, Weishaupt D, Wiarda B, Laghi A (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. Journal of Crohn's & colitis 7 (7):556-585. https://doi.org/10.1016/j.crohns.2013.02.020 CrossRef

22.

Baker ME, Hara AK, Platt JF, Maglinte DD, Fletcher JG (2015) CT enterography for Crohn's disease: optimal technique and imaging issues. Abdom Imaging 40 (5):938-952. https://doi.org/10.1007/s00261-015-0357-4 CrossRefPubMed

23.

Grand DJ, Guglielmo FF, Al-Hawary MM (2015) MR enterography in Crohn's disease: current consensus on optimal imaging technique and future advances from the SAR Crohn's disease-focused panel. Abdom Imaging 40 (5):953-964. https://doi.org/10.1007/s00261-015-0361-8 CrossRefPubMed

24.

Mansuri I, Fletcher JG, Bruining DH, Kolbe AB, Fidler JL, Samuel S, Tung J (2017) Endoscopic Skipping of the Terminal Ileum in Pediatric Crohn Disease. AJR Am J Roentgenol 208 (6):W216-W224. https://doi.org/10.2214/AJR.16.16575 CrossRefPubMed

25.

Samuel S, Bruining DH, Loftus EV, Jr., Becker B, Fletcher JG, Mandrekar JN, Zinsmeister AR, Sandborn WJ (2012) Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 10 (11):1253-1259. https://doi.org/10.1016/j.cgh.2012.03.026 CrossRefPubMed

26.

Faubion WA, Jr., Fletcher JG, O'Byrne S, Feagan BG, de Villiers WJ, Salzberg B, Plevy S, Proctor DD, Valentine JF, Higgins PD, Harris JM, Diehl L, Wright L, Tew GW, Luca D, Basu K, Keir ME (2013) EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging. The American journal of gastroenterology 108 (12):1891-1900. https://doi.org/10.1038/ajg.2013.354 CrossRefPubMed

27.

Sandborn WJ (2014) Crohn's disease evaluation and treatment: clinical decision tool. Gastroenterology 147 (3):702-705CrossRefPubMed

28.

(2018). www.crohnscolitiscongress.org. Accessed 10-29-2018

29.

Coimbra AJ, Rimola J, O'Byrne S, Lu TT, Bengtsson T, de Crespigny A, Luca D, Rutgeerts P, Bruining DH, Fidler JL, Sandborn WJ, Santillan CS, Higgins PD, Al-Hawary MM, Vermeire S, Vanbeckevoort D, Vanslembrouck R, Peyrin-Biroulet L, Laurent V, Herrmann KA, Panes J (2016) Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation. Alimentary pharmacology & therapeutics 43 (1):61-72. https://doi.org/10.1111/apt.13453 CrossRef

30.

Shah SC, Colombel JF, Sands BE, Narula N (2016) Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. Alimentary pharmacology & therapeutics 43 (3):317-333. https://doi.org/10.1111/apt.13475 CrossRef

31.

Colombel JF, Panaccione R, Bossuyt P, Lukas M, Baert F, Vanasek T, Danalioglu A, Novacek G, Armuzzi A, Hebuterne X, Travis S, Danese S, Reinisch W, Sandborn WJ, Rutgeerts P, Hommes D, Schreiber S, Neimark E, Huang B, Zhou Q, Mendez P, Petersson J, Wallace K, Robinson AM, Thakkar RB, D'Haens G (2018) Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet (London, England) 390 (10114):2779-2789. https://doi.org/10.1016/S0140-6736(17)32641-7 CrossRef

32.

Rimola J, Alfaro I, Fernandez-Clotet A, Castro-Poceiro J, Vas D, Rodriguez S, Masamunt MC, Ordas I, Ricart E, Panes J (2018) Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remission. Alimentary pharmacology & therapeutics 48 (11-12):1232-1241. https://doi.org/10.1111/apt.15013 CrossRef

33.

Ordas I, Rimola J, Rodriguez S, Paredes JM, Martinez-Perez MJ, Blanc E, Arevalo JA, Aduna M, Andreu M, Radosevic A, Ramirez-Morros AM, Pino S, Gallego M, Jauregui-Amezaga A, Ricart E, Panes J (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 146 (2):374-382 e371. https://doi.org/10.1053/j.gastro.2013.10.055

34.

Fernandes SR, Rodrigues RV, Bernardo S, Cortez-Pinto J, Rosa I, da Silva JP, Goncalves AR, Valente A, Baldaia C, Santos PM, Correia L, Venancio J, Campos P, Pereira AD, Velosa J (2017) Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease. Inflamm Bowel Dis 23 (8):1403-1409. https://doi.org/10.1097/MIB.0000000000001143 CrossRefPubMed

35.

Sauer CG, Middleton JP, McCracken C, Loewen J, Braithwaite K, Alazraki A, Martin DR, Kugathasan S (2016) Magnetic Resonance Enterography Healing and Magnetic Resonance Enterography Remission Predicts Improved Outcome in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 62 (3):378-383. https://doi.org/10.1097/MPG.0000000000000976 CrossRefPubMed

36.

Bruining DH, Loftus EV, Jr., Ehman EC, Siddiki HA, Nguyen DL, Fidler JL, Huprich JE, Mandrekar JN, Harmsen WS, Sandborn WJ, Fletcher JG (2011) Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease. Clin Gastroenterol Hepatol 9 (8):679-683 e671. https://doi.org/10.1016/j.cgh.2011.04.025

37.

Wu YW, Tang YH, Hao NX, Tang CY, Miao F (2012) Crohn's disease: CT enterography manifestations before and after treatment. Eur J Radiol 81 (1):52-59. https://doi.org/10.1016/j.ejrad.2010.11.010 CrossRefPubMed

38.

Deepak P, Fletcher JG, Fidler JL, Barlow JM, Sheedy SP, Kolbe AB, Harmsen WS, Loftus EV, Hansel SL, Becker BD, Bruining DH (2016) Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease. The American journal of gastroenterology 111 (7):997-1006. https://doi.org/10.1038/ajg.2016.177 CrossRefPubMed

39.

Deepak P, Fletcher JG, Fidler JL, Barlow JM, Sheedy SP, Kolbe AB, Harmsen WS, Therneau T, Hansel SL, Becker BD, Loftus EV, Jr., Bruining DH (2018) Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn’s Disease. Inflamm Bowel Dis. https://doi.org/10.1093/ibd/izy074

40.

Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV, Jr., Marteau P, Munkholm P, Murdoch TB, Ordas I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF (2015) Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. The American journal of gastroenterology 110 (9):1324-1338. https://doi.org/10.1038/ajg.2015.233 CrossRefPubMed

41.

Miles A, Bhatnagar G, Halligan S, Gupta A, Tolan D, Zealley I, Taylor SA (2018) Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn’s disease: patient acceptability and perceived burden. European radiology. https://doi.org/10.1007/s00330-018-5661-2

42.

Puylaert CAJ, Schuffler PJ, Naziroglu RE, Tielbeek JAW, Li Z, Makanyanga JC, Tutein Nolthenius CJ, Nio CY, Pendse DA, Menys A, Ponsioen CY, Atkinson D, Forbes A, Buhmann JM, Fuchs TJ, Hatzakis H, van Vliet LJ, Stoker J, Taylor SA, Vos FM (2018) Semiautomatic Assessment of the Terminal Ileum and Colon in Patients with Crohn Disease Using MRI (the VIGOR++ Project). Academic radiology 25 (8):1038-1045. https://doi.org/10.1016/j.acra.2017.12.024 CrossRefPubMed

43.

Rieder F, Bettenworth D, Ma C, Parker CE, Williamson LA, Nelson SA, van Assche G, Di Sabatino A, Bouhnik Y, Stidham RW, Dignass A, Rogler G, Taylor SA, Stoker J, Rimola J, Baker ME, Fletcher JG, Panes J, Sandborn WJ, Feagan BG, Jairath V (2018) An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Alimentary pharmacology & therapeutics 48 (3):347-357. https://doi.org/10.1111/apt.14853 CrossRef

44.

Stidham RW, Higgins PD (2016) Imaging of intestinal fibrosis: current challenges and future methods. United European gastroenterology journal 4 (4):515-522. https://doi.org/10.1177/2050640616636620 CrossRefPubMedPubMedCentral

Title: Differences in the imaging of Crohn’s disease patients between North America and Europe: are we ready to bridge the divide?
Authors: Stuart A. Taylor
Florian Rieder
Joel G. Fletcher
Publication date: 01-05-2019
Publisher: Springer US
Published in: Abdominal Radiology / Issue 5/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-018-1872-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Differences in the imaging of Crohn’s disease patients between North America and Europe: are we ready to bridge the divide?

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2019

Usefulness of rapid kV-switching dual energy CT in renal tumor characterization

The “enlarged hilar periportal space sign” in liver cirrhosis

The “sigmoid” esophagus

Acquired diverticular disease of the jejunum and ileum: imaging features and pitfalls

Prediction of liver remnant regeneration after living donor liver transplantation using preoperative CT texture analysis

Magnetic resonance cholangiopancreatography using optimized integrated combination with parallel imaging and compressed sensing technique

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page